Cases 21 - 30 of 122
Aragon Pharmaceuticals, Inc. et al v. Lupin Limited et al
as 1:2022cv00637
Plaintiff:
Aragon Pharmaceuticals, Inc., Janssen Biotech, Inc. and Sloan Kettering Institute for Cancer Research
Defendant:
Lupin Limited and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Exeltis USA, Inc. et al v. Lupin Ltd. et al
as 1:2022cv00434
Counter Defendant:
Exeltis USA, Inc., Laboratorios Leon Farma, S.A., Chemo Iberica, S.A. and others
Counter Claimant:
Lupin Ltd. and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation
as 1:2021md03017
In Re:
Xarelto (Rivaroxaban) ('310) Patent Litigation
Not Classified By Court:
Clerk of MDL Panel, Lupin Limited, Lupin Pharmaceuticals, Inc. and others
Counter Defendant:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
ScieGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Gilead Sciences, Inc. et al v. Lupin Limited et al
as 1:2021cv01621
Plaintiff:
Gilead Sciences, Inc., Gilead Sciences Ireland UC, Janssen Products, L.P. and others
Defendant:
Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd. and others
Cause Of Action: 35 U.S.C. § 1
ViiV Healthcare Company et al v. Lupin Limited et al
as 1:2021cv01561
Plaintiff:
ViiV Healthcare Company, Shionogi & Co., Ltd. and ViiV Healthcare UK (No. 3) Limited
Defendant:
Lupin Limited and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. v. Lupin Ltd. et al
as 1:2021cv01486
Plaintiff:
Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH and Boehringer Ingelheim Corporation
Defendant:
Lupin Ltd. and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Neurocrine Biosciences, Inc. v. Lupin Limited et al
as 1:2021cv01408
Plaintiff:
Neurocrine Biosciences, Inc.
Defendant:
Lupin Limited, Lupin Pharmaceuticals, Inc., Lupin Inc. and others
Cause Of Action: 35 U.S.C. § 271
Supernus Pharmaceuticals, Inc. v. Lupin Limited et al
as 1:2021cv01293
Plaintiff:
Supernus Pharmaceuticals, Inc.
Defendant:
Lupin Limited, Lupin Atlantis Holdings S.A., Nanomi B.V. and others
Cause Of Action: 28 U.S.C. § 1338
Neurocrine Biosciences, Inc. v. Lupin Limited et al
as 1:2021cv01042
Plaintiff:
Neurocrine Biosciences, Inc.
Defendant:
Lupin Limited, Lupin Pharmaceuticals, Inc., Lupin Inc. and others
Cause Of Action: 35 U.S.C. § 271
Vertex Pharmaceuticals Incorporated v. Lupin Limited et al
as 1:2021cv01019
Counter Defendant:
Vertex Pharmaceuticals Incorporated
Counter Claimant:
Lupin Limited and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
